200
Participants
Start Date
April 24, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
BDP/FF/G
"BDP/FF/G is an extrafine single inhaler triple therapy available in two dosage strengths:~* Medium strength (MS) containing 100 µg of beclomethasone dipropionate, 6 µg of formoterol fumarate dihydrate and 10 µg of glycopyrronium (as 12.5 µg glycopyrronium bromide);~* High strength (HS) containing 200 µg of beclomethasone dipropionate, 6 µg of formoterol fumarate dihydrate and 10 µg of glycopyrronium (as 12.5 µg glycopyrronium bromide)."
U.O. Clinica Psichiatrica e SPDC. Ospedale Policlinico S. Martino - IRCCS, Genova, Genoa
Gesellschaft für Therapieforschung mbH
INDUSTRY
Chiesi Italia
INDUSTRY